AvePoint chief legal officer Brian Brown sells $574,700 in stock

Brian Brown, Chief Legal Officer and a director at AvePoint, Inc. (NASDAQ:AVPT), sold 35,000 shares of the company’s common stock for a total value of $574,700. The transaction occurred on October 23, 2026, with shares sold at a price of $16.42 each. The sale came as AvePoint’s stock trades near its 52-week high of $16.89, with shares currently at $16.85. The company has delivered strong returns recently, gaining 14% over the past week and 71% over six months, giving it a market capitalization of $3.56 billion. According to InvestingPro analysis, the stock remains slightly undervalued relative to its Fair Value estimate.

The sale was carried out under a Rule 10b5-1 trading plan, which Mr. Brown established on December 16, 2025. Following this transaction, Mr. Brown beneficially owns 224,604 shares of AvePoint common stock. These shares are held indirectly through the Brian M. Brown Revocable Trust, for which Mr. Brown serves as a trustee. Mr. Brown disclaims beneficial ownership of these shares except to the extent of his pecuniary interest.

In other recent news, Avepoint Inc. has been the focus of several analyst firms, each expressing confidence in the company’s growth potential. BMO Capital initiated coverage on Avepoint with an outperform rating, setting a price target of $17. The firm highlighted Avepoint’s strong position in addressing data management needs amid the growing importance of AI and agent adoption, forecasting an annual recurring revenue (ARR) compound annual growth rate (CAGR) of over 20% in constant currency over the next few years. D.A. Davidson reiterated its Buy rating with a price target of $18, suggesting that Avepoint is likely to surpass the consensus third-quarter net new ARR estimate of $27.5 million, with their own estimate pegged at approximately $30 million. Cantor Fitzgerald maintained an Overweight rating and a $15 price target, following a virtual discussion with Avepoint’s top executives. Stephens also raised its price target to $17 while keeping an Overweight rating, citing AI tailwinds as a significant factor in driving Avepoint’s mid-20% ARR growth. These recent developments indicate strong analyst confidence in Avepoint’s strategic direction and growth prospects.